Literature DB >> 30337104

American Gastroenterological Association Institute Technical Review on the Medical Management of Opioid-Induced Constipation.

Brian Hanson1, Shazia Mehmood Siddique2, Yolanda Scarlett3, Shahnaz Sultan4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30337104      PMCID： PMC6685294          DOI： 10.1053/j.gastro.2018.08.018

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  54 in total

1.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

2.  Sodium picosulfate in opioid-induced constipation: results of an open-label, prospective, dose-ranging study.

Authors:  Robert G Twycross; Paul McNamara; Chris Schuijt; Michael A Kamm; Chris Jordan
Journal:  Palliat Med       Date:  2006-06       Impact factor: 4.762

3.  Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire.

Authors:  Patrick Marquis; Christine De La Loge; Dominique Dubois; Anne McDermott; Olivier Chassany
Journal:  Scand J Gastroenterol       Date:  2005-05       Impact factor: 2.423

4.  Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients.

Authors:  Neal Slatkin; Jay Thomas; Arthur G Lipman; George Wilson; Michelle L Boatwright; Charles Wellman; Donna S Zhukovsky; Richard Stephenson; Russell Portenoy; Nancy Stambler; Robert Israel
Journal:  J Support Oncol       Date:  2009 Jan-Feb

5.  Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain.

Authors:  Lynn Webster; Jan Peter Jansen; John Peppin; Ben Lasko; Gordon Irving; Bart Morlion; Jerry Snidow; Amy Pierce; Eric Mortensen; Christi Kleoudis; Eric Carter
Journal:  Pain       Date:  2007-12-31       Impact factor: 6.961

6.  Psychometric performance and clinical meaningfulness of the Patient Assessment of Constipation-Quality of Life questionnaire in prucalopride (RESOLOR) trials for chronic constipation.

Authors:  D Dubois; H Gilet; M Viala-Danten; J Tack
Journal:  Neurogastroenterol Motil       Date:  2009-09-17       Impact factor: 3.598

7.  Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study.

Authors:  Russell K Portenoy; Jay Thomas; Michele L Moehl Boatwright; Diep Tran; Frank L Galasso; Nancy Stambler; Charles F Von Gunten; Robert J Israel
Journal:  J Pain Symptom Manage       Date:  2008-05       Impact factor: 3.612

8.  A survey of chronic noncancer pain patients prescribed opioid analgesics.

Authors:  David T Cowan; Jenifer Wilson-Barnett; Peter Griffiths; Laurie G Allan
Journal:  Pain Med       Date:  2003-12       Impact factor: 3.750

9.  Methylnaltrexone for opioid-induced constipation in advanced illness.

Authors:  Jay Thomas; Sloan Karver; Gail Austin Cooney; Bruce H Chamberlain; Charles Kevin Watt; Neal E Slatkin; Nancy Stambler; Alton B Kremer; Robert J Israel
Journal:  N Engl J Med       Date:  2008-05-29       Impact factor: 91.245

10.  Impact of constipation on opioid use patterns, health care resource utilization, and costs in cancer patients on opioid therapy.

Authors:  Sean D Candrilli; Keith L Davis; Shrividya Iyer
Journal:  J Pain Palliat Care Pharmacother       Date:  2009
View more
  6 in total

1.  A pilot randomized placebo-controlled study on modified MaZiRenWan: a formulated Chinese medicine to relieve constipation for palliative cancer patients.

Authors:  Chung-Wah Cheng; Hoi-Fung Mok; Cora W S Yau; Jasmine T M Chan; Yu-Chen Kang; Pui-Yan Lam; Linda L D Zhong; Chen Zhao; Bacon F L Ng; Annie O L Kwok; Doris M W Tse; Zhao-Xiang Bian
Journal:  Chin Med       Date:  2022-03-02       Impact factor: 5.455

2.  Effects of Maren Pills on the Intestinal Microflora and Short-Chain Fatty Acid Profile in Drug-Induced Slow Transit Constipation Model Rats.

Authors:  Yu Zhan; Yong Wen; Li-Juan Du; Xiao-Xiang Wang; Shi-Yu Tang; Peng-Fei Kong; Wei-Guo Huang; Xue-Gui Tang
Journal:  Front Pharmacol       Date:  2022-04-12       Impact factor: 5.988

3.  Bifidobacterium lactis TY-S01 Prevents Loperamide-Induced Constipation by Modulating Gut Microbiota and Its Metabolites in Mice.

Authors:  Tian Tang; Jing Wang; Yuanyuan Jiang; Xu Zhu; Zhen Zhang; Yuying Wang; Xi Shu; Yadan Deng; Feng Zhang
Journal:  Front Nutr       Date:  2022-06-29

4.  Abnormal bile acid metabolism is an important feature of gut microbiota and fecal metabolites in patients with slow transit constipation.

Authors:  Yadong Fan; Chen Xu; Lulu Xie; Ying Wang; Shan Zhu; Jiren An; Yuwei Li; Zhikui Tian; Yiqi Yan; Shuang Yu; Haizhao Liu; Beitian Jia; Yiyang Wang; Li Wang; Long Yang; Yuhong Bian
Journal:  Front Cell Infect Microbiol       Date:  2022-07-28       Impact factor: 6.073

Review 5.  Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel.

Authors:  Roberto De Giorgio; Furio Massimino Zucco; Giuseppe Chiarioni; Sebastiano Mercadante; Enrico Stefano Corazziari; Augusto Caraceni; Patrizio Odetti; Raffaele Giusti; Franco Marinangeli; Carmine Pinto
Journal:  Adv Ther       Date:  2021-06-04       Impact factor: 3.845

Review 6.  Opioid-induced Constipation: A Review of Health-related Quality of Life, Patient Burden, Practical Clinical Considerations, and the Impact of Peripherally Acting μ-Opioid Receptor Antagonists.

Authors:  Charles E Argoff
Journal:  Clin J Pain       Date:  2020-09       Impact factor: 3.423
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.